Caffeine boosts Ataluren's readthrough activity
The readthrough of nonsense mutations by small molecules like Ataluren is considered a novel therapeutic approach to overcome the gene defect in several genetic diseases as cystic fibrosis (CF). This pharmacological approach suppresses translation termination at premature termination codons (PTCs re...
Main Authors: | Laura Lentini, Raffaella Melfi, Patrizia Cancemi, Ivana Pibiri, Aldo Di Leonardo |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-06-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844019355744 |
Similar Items
-
Ataluren—Promising Therapeutic Premature Termination Codon Readthrough Frontrunner
by: Sylwia Michorowska
Published: (2021-08-01) -
A Simple and Affordable Method to Create Nonsense Mutation Clones of p53 for Studying the Premature Termination Codon Readthrough Activity of PTC124
by: Chia-Chi Chen, et al.
Published: (2023-04-01) -
Integrity and Stability of PTC Bearing CFTR mRNA and Relevance to Future Modulator Therapies in Cystic Fibrosis
by: Luka A. Clarke, et al.
Published: (2021-11-01) -
Functional Restoration of BRCA1 Nonsense Mutations by Aminoglycoside-Induced Readthrough
by: Renata B. V. Abreu, et al.
Published: (2022-06-01) -
Pharmaceuticals Promoting Premature Termination Codon Readthrough: Progress in Development
by: Shan Li, et al.
Published: (2023-06-01)